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Background:  New permanent pacemaker implantations (PPI) and postprocedural intraventricular conduction abnormalities (CA) remain 
a serious concern after transcatheter aortic valve replacement (TAVR). Recently, a new generation balloon expandable prosthesis, the 
Edwards SAPIEN 3 (ES3, Edwards Lifesciences, Irvine, CA, USA) has replaced the SAPIEN XT (ESXT). This single center observational 
trial sought to determine the incidence of new-onset CA and PPI using the ES3 compared with the ESXT.
methods:  We analyzed 208 consecutive patients undergoing TAVR using the ESXT (n=103) and the ES3 (n=105). In order to determine 
the incidence of new PPI and CA, patients with a prior pacemaker and CA at baseline were excluded. ECGs were recorded at baseline, 
after TAVR and before discharge.
results:  In comparison to the ESXT, the ES3 was associated with a significantly higher device success rate (100% vs. 92%, p<0.001) and 
less paravalvular leakage (grade 2+, 0% vs. 7%, p<0.001). In the entire patient population we found an overall incidence of PPI of 12.6% 
(23/183) with no difference between both groups (ES3: 12.5% (12/96) vs. ESXT: 12.6% (11/87), p=0.99). The incidence of new-onset CA 
was higher in the ES3 group as compared to the ESXT (49% vs. 27%, p=0.007). This finding was mainly the result of a higher rate of 
fascicular blocks (17% vs. 5%, p=0.021), while we found no statistical difference in transient (ES3: 29% (20/69) vs. ESXT: 18% (12/67), 
p=0.128) and persistent left bundle branch blocks (ES3: 28% (19/69) vs. ESXT: 16% (11/67), p=0.118).
conclusion:  We found a trend towards a higher rate of new-onset CA using the ES3 when compared to the ESXT. However, this finding 
did not translate into a higher PPI rate.
